ESMO 2022 Conference Coverage
Head and Neck
ESMO 2022 Conference Coverage
ESMO 2022 H&N Updates
FEATURING
Nabil Saba
- 786 views
- September 30, 2022
- 5
ESMO 2022 Conference Coverage
ESMO 2022 on the Phase 4 KEYNOTE-B10 Study: Pembro + Carbo + Paclitaxel as 1L Therapy in Recurrent/Metastatic HNSCC
FEATURING
Marcin Dzienis
- 67 views
- September 30, 2022
- 1
ESMO 2022 Conference Coverage
ESMO 2022: Contemporary Approach to the Multidisciplinary Management of Sinonasal Cancer
FEATURING
Paolo Bossi
- 51 views
- September 22, 2022
- 1
ESMO 2022 Conference Coverage
Lecture Summary - ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma
FEATURING
Han Chong Toh
- 11 views
- September 22, 2022
ESMO 2022 Conference Coverage
ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma
FEATURING
Han Chong Toh
- 59 views
- September 22, 2022
ESMO 2022 Conference Coverage
Lecture Summary - ESMO 2022 on Multi-Omic Profiling in H&N Cancer: Clinical Applications
FEATURING
Inge Tinhofer
- 11 views
- September 21, 2022
ESMO 2022 Conference Coverage
ESMO 2022 on Multi-Omic Profiling in H&N Cancer: Clinical Applications
FEATURING
Inge Tinhofer
- 82 views
- September 21, 2022
- 1
ESMO 2022 Conference Coverage
ESMO 2022: NGS Helps Predict Response to IO in Recurrent/Metastatic HNSCC Patients
FEATURING
Oriol Mirallas
- 216 views
- September 19, 2022
- 1
ESMO 2022 Conference Coverage
ESMO 2022 Evaluation of the DNA Damage Response Network as a Predictor of Nivolumab Efficacy in HNSCC
FEATURING
Panagiota Oikonomopoulou
- 93 views
- September 19, 2022
- 1
ESMO 2022 Conference Coverage
ESMO 2022 Liquid Biopsy for Detection of Molecular Residual Disease and Recurrence in Head and Neck Squamous Cell Carcinoma
FEATURING
Susanne Flach
- 91 views
- September 14, 2022
- 1